Skip to main content
15 October 2026
Last updated: Thursday 15 October 2026

User account anon menu

  • Login
  • Register and subscribe
Home
  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form
Menu

Breadcrumb

  1. Home
  2. Research Directory

Research Directory

How European MidPharmas have grown profits

Sunday 27 March 2022
Interviewee/Contributor
Katherine Smith
Organisation
Novasecta
Read more

Organisations

  • NDA Regulatory Science Ltd
  • Abivax SA
  • Shire Plc
  • MedCity
  • Aduro Biotech Inc
  • IP Group
  • Altheia Science Srl
  • Karolinska Institutet
  • Molecular Health GmbH
  • Wemedoo AG

Interviewees and Contributers

  • Antoine Papiernik
  • Petter Björquist
  • Jacques Thèze
  • Greg Mullen
  • Rosanne Dunn
  • Shaun Grady
  • Niall Martin and Jonathan Tobin
  • Ruth March
  • David Moller
  • John Foerster

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Evotec appoints CSO

Thursday 15 October 2026

New CEO at AL-S Pharma

Wednesday 14 October 2026

Bavarian Nordic appoints new CEO

Monday 12 October 2026

Leadership transition at Nuclera

Monday 12 October 2026

HMNC insider named CEO

Monday 12 October 2026
View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

  • News
  • Industry appointments
  • Events
  • Research directory
  • Subscribe

Footer

  • Privacy policy

© 2026 Evernow Publishing Ltd.

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form